Three-year prospective evaluation of glucose tolerance, β-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major

被引:26
作者
Messina, MF [1 ]
Lombardo, F [1 ]
Meo, A [1 ]
Miceli, M [1 ]
Wasniewska, M [1 ]
Valenzise, M [1 ]
Ruggeri, C [1 ]
Arrigo, T [1 ]
De Luca, F [1 ]
机构
[1] Univ Messina, Policlin, Dipartimento Pediat, I-98123 Messina, Italy
关键词
diabetes mellitus; glucose intolerance; insulin secretion; insulin sensitivity; thalassemia major;
D O I
10.1007/BF03345490
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The aim of this prospective study was to evaluate the evolution of glucose tolerance (GT), insulin secretion and peripheral insulin sensitivity during a 3-yr follow-up in a homogenous population consisting of fourteen non-diabetic adults with thalassemia major (TIVI). All the patients underwent 2 OGTTs with a 3-yr interval and random measurements of fasting glycemia during the entire follow-up. At the time of both OGTTs, peripheral insulin sensitivity was assessed by both homeostatic model assessment (HOMA) index and a novel index derived from the OGTT. At the second OGTT patients exhibited both significantly higher fasting glucose concentrations and enhanced glycemic responses, with greater average glucose areas. GT deterioration over time was accompanied by a reduction of insulin sensitivity, with no concomitant change of insulin secretion. No patient developed diabetes mellitus (DM) during follow-up. To conclude, the natural history of glycometabolic status in TIVI adults seems to be characterized by a GT deterioration over time, which may probably reflect an increase of insulin resistance. GT deterioration is more evident in patients with the highest responses to the 1(st) OGTT and particularly in those with pre-existing impaired GT. (C) 2002, Editrice Kurtis.
引用
收藏
页码:497 / 501
页数:5
相关论文
共 20 条
[1]
ARRIGO T, 1998, J PEDIAT ENDOCRINOL, V11, P389
[2]
THE EUGLYCEMIC CLAMP IN PATIENTS WITH THALASSEMIA INTERMEDIA [J].
BRIANDA, S ;
MAIOLI, M ;
FRULIO, T ;
DORE, F ;
LONGINOTTI, M ;
FRACASSO, D ;
CAMPUS, S .
HORMONE AND METABOLIC RESEARCH, 1987, 19 (07) :319-322
[3]
INSULIN-RESISTANCE AND HYPERINSULINEMIA IN HOMOZYGOUS BETA-THALASSEMIA [J].
CAVALLOPERIN, P ;
PACINI, G ;
CERUTTI, F ;
BESSONE, A ;
CONDO, C ;
SACCHETTI, L ;
PIGA, A ;
PAGANO, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (03) :281-286
[4]
DESANCTIS V, 1995, CLIN ENDOCRINOL, V42, P581
[5]
FACTORS DETERMINING GLUCOSE-TOLERANCE IN PATIENTS WITH THALASSEMIA MAJOR [J].
DMOCHOWSKI, K ;
FINEGOOD, DT ;
FRANCOMBE, W ;
TYLER, B ;
ZINMAN, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :478-483
[6]
ELLIS JT, 1954, AM J PATHOL, V30, P287
[7]
FINK H, 1964, ANN NY ACAD SCI, V119, P680
[8]
GALIMBERTI M, 1995, ENDOCRINE DISORDERS, P161
[9]
A prospective analysis of the HOMA model - The Mexico City Diabetes Study [J].
Haffner, SM ;
Gonzalez, C ;
Miettinen, H ;
Kennedy, E ;
Stern, MP .
DIABETES CARE, 1996, 19 (10) :1138-1141
[10]
HYPERINSULINEMIA IN A POPULATION AT HIGH-RISK FOR NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
HAFFNER, SM ;
STERN, MP ;
HAZUDA, HP ;
PUGH, JA ;
PATTERSON, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) :220-224